The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker ...

General Anil Chauhan engaged in a series of high-level interactions with top military and defence industry leaders, highlighting India’s commitment to forging strategic defence partnerships and ...

The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...

Biden’s decision underscored two key challenges with the current CFIUS process: the absence of a clear tiered framework to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...

We recently published a list of 10 Best Stocks To Buy For Financial Stability. In this article, we are going to take a look ...

Aussies are set to spend a whopping $535m on Valentine’s Day gifts for their partners this year, according to market ...

Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...